Skip to main content

Table 3 HRCT scores in men and women with TB at differential time point of anti-TB treatment

From: Sex influences the association between haemostasis and the extent of lung lesions in tuberculosis

  Female (n = 15) Male (n = 7)
HRCT scores T0 16.8 (11.23, 22.37) 25.86 (15.19, 36.53)
T1 13.53 (8.45, 18.62) 23.86 (14.8, 32.91)
T3 10.00 (4.89, 15.11) 18.71 (10.24, 27.19)
P valuea < 0.001 0.001
P valueb 0.044  
Weighted HRCT scores T0 38.13 (23.51, 52.75) 48.71 (23.48, 73.95)
T1 32.20 (17.48, 46.92) 52.43 (30.16, 74.69)
T3 23.33 (9.54, 37.13) 41.57 (17.28, 65.86)
P valuea 0.003 0.295
P valueb 0.158  
  1. HRCT high-resolution computed tomography, T0 time of registration in SPH and before anti-TB treatment, T1 about 1 month after T0, T3 about 3 months after T0
  2. Data are displayed as means and lower and upper bounds of 95% confidence interval
  3. aANOVA tests with single-factor repeated measures compare the difference of scores at T0, T1 and T3 in female or male TB patients
  4. bANOVA tests with multiple-factor repeated measures compare the changes of scores at T0, T1 and T3 between female and male TB patients
  5. Italicized numbers indicate a P value of < 0.05